Medical Devices Investors & VC Firms in Austin
13 firms in this list, with a median first check of $500K. 5 of them lead rounds. Generated from verified public data and updated continuously.
Breyer Capital
AustinPre-Seed–Series A$500K – $10M
7 people
S3 Ventures
AustinSeed–Series B$500K – $15M
12 people
Sante Ventures
AustinSeed–Series A$2M – $6M
36 people
Unorthodox Ventures
AustinSeed–Growth$1M – $5M
16 people
Next Ventures
AustinSeed–Series A$500K – $3M
9 people
JStar Capital Investments
AustinSeed–Series C
13 people
Ecliptic Capital
AustinPre-Seed–Series A$50K – $5M
9 people
Julian Capital
AustinPre-Seed–Seed$500K – $2M
3 people
TEXO Ventures
AustinSeed–Series A
4 people
Cartmell Ventures
AustinPre-Seed–Seed
3 people
Emergent Technologies, Inc.
AustinSeed–Series A
4 people
UT Horizon Fund
AustinSeed–Series A
AgeTech Capital
TorontoSeed–Growth
16 people
Frequently asked questions
- Who are the top medical devices investors & vc firms in austin?
- Top medical devices investors & vc firms in austin include Breyer Capital, S3 Ventures, Sante Ventures, Unorthodox Ventures, Next Ventures, JStar Capital Investments, Ecliptic Capital, Julian Capital — 13 firms in total meet the criteria.
- What is the typical first check among medical devices investors & vc firms in austin?
- The median first check among the 13 medical devices investors & vc firms in austin tracked here is $500K.
- How many medical devices investors & vc firms in austin lead rounds?
- 5 of the 13 medical devices investors & vc firms in austin tracked here lead investment rounds.
Related lists
Investors & VC Firms in North America (12929)Investors & VC Firms in United States (11967)Investors & VC Firms in Europe (5859)Investors & VC Firms in Global (4787)AI & Machine Learning Investors & VC Firms (4629)Fintech Investors & VC Firms (4588)SaaS Investors & VC Firms (4239)Healthtech Investors & VC Firms (4227)Enterprise Software Investors & VC Firms (4136)Crypto & Web3 Investors & VC Firms (3986)
Data sourced from public filings and firms' own websites — see our methodology.


















































